Manifestation of Kawasaki Disease under the Covid-19 Clinical Spectrum: a systematic literature review
DOI:
https://doi.org/10.33448/rsd-v10i11.19852Keywords:
Covid-19; Kawasaki Disease; Multisystemic disease; Kids.Abstract
Introduction: Children affected by Covid-19, the picture of hyperinflammation presented showed changes in the coronary arteries, characteristic of Kawasaki disease (KD). Children present with persistent high fever, rash, swelling of the extremities, non-purulent conjunctivitis, abdominal pain, vomiting, and diarrhea. Objective: to present the scientific evidence available so far, which brings an existing association between Kawasaki Covid-19 Disease in children. Methodology: This is a literature review carried out between June and July 2021, in the following databases: Virtual Health Library (VHL), Google Scholar, Scientific Electronic Library Online (SciELO) and National Library of Medicine (PubMed MEDLINE). Results and discussion: It is suggested that the mechanism of KD is based on an antibody-mediated post-inflammatory reaction, thus, the identification of viral replication was not truly relevant in these cases. In addition to the link between the Covid-19 pandemic and the increase in DK cases, another period where there was a peak in DK incidence was during the context of the H1N1 pandemic, suggesting that SARS-CoV-2 is not the only virus capable of trigger such emergence of Kawasaki disease. Conclusion: Despite the more severe manifestations in patients affected by Covid-19, the occurrence of KD associated with Covid-19 is not very frequent, however, it is important to be aware of the signs and symptoms of the disease in order to obtain the earliest possible diagnosis. and proceed with the appropriate treatment, in order to avoid the occurrence of complicated or aggravated clinical conditions.
References
Akca, U. K., Kesici, S., Ozsurekci, Y., Aykan, H. H., Batu, E. D., Atalay, E., Demir, S., Sag, E., Vuralli, D., Bayrakci, B., Bilginer, Y. & Ozen, S. (2020). Kawasaki‑like disease in children with COVID‑19. Rheumatology, 40 (1), 2105-2115.
Alizargar, J. (2020). The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children. Journal of the Formosan Medical Association, 1-2. https://doi.org/10.1016/j.jfma.2020.05.030
Amirfakhryan, H. (2020). Kawasaki-like disease in children with COVID-19: A hypothesis. Medical Hypotheses, 143 (110117), 1-4. https://doi.org/10.1016/j.mehy.2020.110117
Bailey, L. C., Razzaghi, H., Burrows, E. K., Bruno, C. & Forrest, C. B. (2020). Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatrics, 175 (2). 176-185.
Campos, L. R., Cardoso, T. M., Martinez, J. C. F. F., Almeida, R. G., Silva, R. M., Fonseca, A. R. & Sztajnbok, F. R. (2020). Síndrome inflamatória multissistêmica pediátrica (MIS-C) temporalmente associada ao COVID-19. Residência Pediátrica, 10 (2), 1-6.
Carvalho, H. T., Thomazi, L., Fioretto, J. R. & Carpi, M. F. (2020). Manifestações graves da doença de Kawasaki em tempos de COVID-19: relato de caso. Residência Pediátrica, 10 (3), 1-5.
Chara, B. S., Rickli, J. M., Silva, C. F., Pomaleski, G. & Gonçalves, M. V. M. (2021). Doença semelhante a Kawasaki, um novo fenótipo em Sars-CoV-2? Int J Cardiovasc Sci, 1-4. https://doi.org/10.36660/ijcs.20200186
Fang, Y., Aravamudan, V. M., Sridharan, G. K. & Abid, M. B. (2021). Kawasaki like illness due to COVID-19: a review of the literature. J Infect Dev Ctries, 15 (5), 630-638.
Figueroa, E. I. R., Santos, R., Simpson, S. & Garg, P. (2020). Incomplete Kawasaki Disease in a Child with COVID-19. Indian Pediatrics, 57 (1), 680-681.
Gonçalves, L. F., Gonzales, A. I., Patatt, F. S. A., Paiva, K. M. & Haas, P. (2020). Kawasaki and COVID-19 disease in children: a systematic review. Rev Assoc Med Bras, 66 (2), 136-142. http://dx.doi.org/10.1590/1806-9282.66.S2.136
Jones, V. G., Milss, M., Suarez, D., Hogan, C. A., Yeh, D., Segal, J. B., Ngyuen, E, L., Barsh, G. R., Maskatia, S. & Mathew, R. (2020). COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hospital Pediatrics, 10 (6), 537-540.
Kaberdoss, J., Pilania, R. K., Karkhele, R., Kumar, T. S. & Danda, D. (2020). Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatology International, 41 (1), 19-32.
Kam, K. Q., Ong, J. S. M. & Lee, J. H. (2020). Kawasaki disease in the COVID-19 era: a distinct clinical phenotype? The Lancet, 4 (1), 641-643. https://doi.org/10.1016/ S2352-4642(20)30207-8
Lessa, A. R., Auer, A. C. R., Freitas, E. N., Lessa, G. R. & Prates, L. S. (2021). Associação de SARS-COV-2 com a doença de Kawasaki. Acervo Saúde, 23 (1), 1-6. https://doi.org/10.25248/REAC.e6462.2021
Loomba, R. S., Villarreal, E. & Flores, S. (2020). COVID-19 and Kawasaki syndrome: should we really be surprised? Cardiology in the Young, 30 (1), 1059-1060.
Ouldali, N., Pouletty, M., Mariani, P., Beyler, C. & Meinzer, U. (2020). Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health, 4642 (20), 30174-30179. https://doi.org/10.1016/S2352-4642(20)30175-9
Pacífico, D. K. S., Silva, F. D. S., Pinto, A. S. B., Junior, E. F. V. & Batista, L. O. (2020). Doença de Kawasaki e COVID-19: uma revisão de literatura. Acervo Saúde, 12 (12), 1-8. https://doi.org/10.25248/reas.e5085.2020
Pousa, P. A., Mendonça, T. S. C., Oliveira, E. A. & Silva, A. C. S. (2021). Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations. Jornal de Pediatria. 97 (2), 116-139.
Riphagen, S., Gomez, X., Martinez, C. G., Wilkinson, N. & Theocharis, P. (2020). Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet, 395 (10237), 1607-1608. https://doi.org/10.1016/S0140-6736(20)31094-1
Rodrigues, J. F. & Eulálio, E. J. C. (2021). Ocorrência de condições inflamatórias pediátricas na COVID-19: uma revisão integrativa. Research, Society and Development, 10 (3), 1-15. http://dx.doi.org/10.33448/rsd-v10i3.13242
Russell, M. V. & Whittaker, E. (2020). Kawasaki-like disease: emerging complication during the COVID-19 pandemic. The Lancet, 395 (1), 1741-1742.
Sandhaus, H., Crosby, D., Sharma, A. & Gregory, S. R. (2020). Associação entre COVID-19 e doença de Kawasaki: vigilância exigida de otorrinolaringologistas. Academia Americana de Otorrinolaringologia, 1-2.
Santos, B. S., Santos, F. S. & Ribeiro, E. R. (2020). Clinical-epidemiological relation between SARS-CoV-2 and Kawasaki disease: an integrative literature. Rev Paul Pediatr, 39 (1), 1-8. http://dx.doi.org/10.1590/1984-0462/2021/39/2020217
Schroeder, A. R., Wilson, K. A. & Ralston, L. S. (2021). Covid-10 and Kawasaki Disease: Finding the Signal in the Noise. Hospital Pediatrics, 10 (10), 1-5.
Silveira, A. C. B., Maia, M. E. D., Zambeli, L. O., Ruela, V. P., Júnior, L. D. M., Cunha, R. M. C. & Alvim, V. F. (2020). Síndrome inflamatória multissistêmica pediátrica induzida por SARS-CoV-2 e similaridades com a doença de Kawasaki, HU Revista, 46 (1), 1-9.
Toubiana, J., Poirault, C., Corsia, A., Bajolle, F., Fourgeaud, J., Angoulvant, F., Debray, A., Basmaci, R., Salvador, E., Biscardi, S., Frange, P. & Chalumeau, M. (2020). Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ, 369 (2094), 1-7.
Volpat, A. T., Gomes, E. M. S., Cunha, E. T., Vilaça, H. M., Mayrink, L. B., Hilarino, L. V. & Alvim, A. L. (2020). Síndrome inflamatória multissistêmica em crianças e adolescentes com COVID-19: uma revisão de literatura. Journal of Infection Control, 9 (3), 162-165.
Xu, S., Chen, M. & Weng, J. (2020). COVID-19 and Kawasaki disease in children. Pharmacological Research, 159 (1), 1-3. https://doi.org/10.1016/j.phrs.2020.104951
Zhang, X., Lei, B, Yuan, Y., Zhang, L., Hu, L., Jin, S., Kang, B., Liao, X., Sun, W., Xu, F., Zhong, Y., Hu, J. & Qi, H. (2020). Brain control of humoral immune responses amenable to behavioural modulation. Nature, 581 (7807), 204-208.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bárbara Queiroz de Figueiredo; Ana Luísa Mota; Francyele dos Reis Amaral; Júlia Fernandes Nogueira; Thainá Gabrielle Miquelanti; Francis Jardim Pfeilsticker
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
